This is when a doctor takes tissue or an organ from one animal and puts it into another animal. For example, they might use pig heart valves in humans.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Xenotransplantation is the transplant of living cells, tissues or organs from an animal into a person. Today it almost always means a kidney or heart from a pig that has been gene-edited so the human immune system is less likely to attack it. The work is driven by a shortage of human organs: in the United States, people die every day while on the waiting list for a transplant. Xenotransplantation is still experimental. It is available only through small studies authorized by the US Food and Drug Administration (FDA) or through case-by-case compassionate use. Pig kidneys are furthest along, and the FDA has allowed several limited studies in adults with kidney failure who face a very long wait for a human kidney, or whose immune system already reacts against most human donors. Pig hearts have been transplanted into two men with end-stage heart failure who could not receive a human heart or an implanted heart pump. Pig livers are being tested only as temporary support while someone waits to recover or to receive a human liver. For almost everyone with organ failure, a human transplant, dialysis or a heart pump remains the standard path. Xenotransplantation is considered when those options are not available in time. Replacement heart valves made from pig or cow tissue are a routine, separate operation and are not what this page describes.
Study teams look for people with life-threatening organ failure who have no timely human organ or other acceptable treatment, who are stable enough to tolerate surgery, and who have the support to keep up with intensive, long-term follow-up. Candidates have blood tests to check whether they already carry antibodies that react against pig cells, along with screening for infections they may already have. Consent goes further than for an ordinary transplant. Recipients agree to lifelong monitoring for infection, to having blood and tissue samples stored for future testing, and to keeping the team informed of where they live. They also agree to tell current and future sexual partners and close household contacts about the possible infection risk, and that those contacts will be asked not to donate blood. Public health agencies may need long-term access to the recipient's medical records. The donor pig is raised in a closed, specially controlled facility and tested repeatedly for viruses and other organisms that could harm a person on strong immune-suppressing drugs.
The organ is removed from the donor pig and often kept on a machine that pumps preserving fluid through it during transport, because pig organs tolerate cold storage poorly. For a kidney, the operation follows the same basic pattern as a standard kidney transplant: under general anesthesia, the surgeon places the new kidney in the lower belly and connects its artery, vein and ureter (the tube that carries urine to the bladder). What differs is the medical management around the surgery. The team gives drugs that block complement, a part of the immune system that can damage a pig organ within minutes of blood flowing through it, and closely tracks clotting, because pig and human clotting systems do not fully match. Any donated blood products may be screened for antibodies against pig cells. In the kidney cases reported so far, the pig kidney began making urine right away.
Recovery begins in the hospital, as with any major transplant. Recipients take several anti-rejection medicines, usually standard transplant drugs plus newer antibody treatments that block the signals immune cells need to attack the organ. Monitoring is more intensive than after a human transplant, with frequent blood tests and planned biopsies (small tissue samples of the organ) to catch rejection early, when it may still respond to treatment. Monitoring for infection continues for life. Recipients and their sexual partners and close household contacts are asked never to donate blood, plasma, tissues, breast milk, eggs or sperm, and recipients are counseled on using barrier protection during sex. Because no one yet knows how long a pig organ will last, the team also plans for what happens if it fails. One man who received a pig kidney returned to dialysis when it was removed, and later received a human kidney. Study teams ask recipients to report fever or any new illness promptly, because infection and rejection both need fast testing in someone on strong anti-rejection drugs.
Rejection is the main obstacle. Even heavily gene-edited pig organs provoke immune attack. In the most closely reported pig kidney case, an early rejection episode was treated successfully, but months later damage to the kidney's small blood vessels, with tiny clots forming inside them, led to its removal after 271 days without dialysis. In the second pig heart recipient, the heart worked well for several weeks, then stiffened and lost its pumping strength, and he chose comfort care after 40 days. So far pig organs have lasted weeks to months, not years. The anti-rejection drugs raise the risk of ordinary infections, and treating an infection by lowering those drugs can open the door to rejection. Pig viruses are a separate concern. A pig virus is thought to have contributed to the failure of at least one pig heart, which is why donor herds are now tested so closely. Spread of a pig infection to the recipient's family or the public has not been seen in any clinical case so far, but it remains a theoretical risk, and it is the reason for lifelong monitoring. Problems with clotting and bleeding are another hazard, especially with pig livers. All of this comes from a handful of patients, so no one can yet give reliable odds of success or survival.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Xenotransplantation, what to expect, or ask the community a question.